TY - JOUR
T1 - Expression and topography of integrins and basement membrane proteins in epidermal carcinomas
T2 - Basal but not squamous cell carcinomas display loss of α6β4 and BM-600/nicein
AU - Savoia, Paola
AU - Trusolino, Livio
AU - Pepino, Eugenio
AU - Cremona, Ottavio
AU - Marchisio, Pier Carlo
N1 - Funding Information:
We tilatlk Michele De Luca, 1ST, Getlova,for s!imulalitlg diswssions and Ra.Daella A lbano Jor skillflll lec/mical Qssislatlce. Supported by AIRC, Associaziol1e Ilaliatla per la Ricerca Sill Catlcro atld by CNR, Cotlsiglio Naziottale delle Ricerche (PF Applicaziotli C/itliche della Ricerca Otlcologica atld PF ItlVecchiametlto). PS is a recipiell! oj a CNR Jellowsh ip.
PY - 1993/9
Y1 - 1993/9
N2 - The expression and topography of some integrins and basement membrane proteins in cutaneous basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) have been studied by immunohistochemistry and Western blotting. It has been shown that the typical cell-to-cell distribution of α2β1 and α3β1 found in normal epidermis is replaced by pericellular distribution in both BCC and SCC cells. BCC and SCC also showed different patterns of expression of α6β4, an integrin heterodimer normally lining the basal surface of basal epidermal keratinocytes: whereas SCC showed high expression and pericellular distribution of α6β4, BCC cells did not express this integrin at all. The absence of α6 and β4 subunits from BCC extracts was confirmed by Western blotting. The molecular composition of the basement membrane was markedly different in the two types of epidermal tumors. Whereas laminin and collagen type IV were conserved in the basement membrane zone of both tumors, the molecular complex BM-600/nicein, which is recognized by the monoclonal antibody GB3 and is possibly identical to the previously described basement membrane glycoproteins kalinin and epiligrin, was absent from BCC cells. Then, the simultaneous loss of expression of α6β4 and BM-600/nicein in BCC cells but not in SCC cells indicates that α6β4 integrin and one of its potential ligands may be co-regulated in both BCC and SCC, thus suggesting a role for this phenomenon in the pathogenesis and clinical behavior of these epidermal tumors.
AB - The expression and topography of some integrins and basement membrane proteins in cutaneous basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) have been studied by immunohistochemistry and Western blotting. It has been shown that the typical cell-to-cell distribution of α2β1 and α3β1 found in normal epidermis is replaced by pericellular distribution in both BCC and SCC cells. BCC and SCC also showed different patterns of expression of α6β4, an integrin heterodimer normally lining the basal surface of basal epidermal keratinocytes: whereas SCC showed high expression and pericellular distribution of α6β4, BCC cells did not express this integrin at all. The absence of α6 and β4 subunits from BCC extracts was confirmed by Western blotting. The molecular composition of the basement membrane was markedly different in the two types of epidermal tumors. Whereas laminin and collagen type IV were conserved in the basement membrane zone of both tumors, the molecular complex BM-600/nicein, which is recognized by the monoclonal antibody GB3 and is possibly identical to the previously described basement membrane glycoproteins kalinin and epiligrin, was absent from BCC cells. Then, the simultaneous loss of expression of α6β4 and BM-600/nicein in BCC cells but not in SCC cells indicates that α6β4 integrin and one of its potential ligands may be co-regulated in both BCC and SCC, thus suggesting a role for this phenomenon in the pathogenesis and clinical behavior of these epidermal tumors.
KW - squamous cell carcinoma/basal cell carcinoma/integrins/basement membrane proteins
UR - http://www.scopus.com/inward/record.url?scp=0027202061&partnerID=8YFLogxK
U2 - 10.1111/1523-1747.ep12365531
DO - 10.1111/1523-1747.ep12365531
M3 - Article
SN - 0022-202X
VL - 101
SP - 352
EP - 358
JO - Journal of Investigative Dermatology
JF - Journal of Investigative Dermatology
IS - 3
ER -